Inozyme Pharma, Inc. - Common Stock, par value $0.0001 per share (INZY)

CUSIP: 45790W108

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
64,967,756
Total 13F shares
17,329,319
Share change
-165,017
Total reported value
$118,150,000
Price per share
$6.82
Number of holders
49
Value change
-$3,845,992
Number of buys
21
Number of sells
22

Quarterly Holders Quick Answers

What is CUSIP 45790W108?
CUSIP 45790W108 identifies INZY - Inozyme Pharma, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Inozyme Pharma, Inc. - Common Stock, par value $0.0001 per share (INZY) as of Q4 2021

As of 31 Dec 2021, Inozyme Pharma, Inc. - Common Stock, par value $0.0001 per share (INZY) was held by 49 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 17,329,319 shares. The largest 10 holders included NEA Management Company, LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Sofinnova Investments, Inc., ADAGE CAPITAL PARTNERS GP, L.L.C., Pivotal bioVenture Partners Investment Advisor LLC, SUVRETTA CAPITAL MANAGEMENT, LLC, CHI Advisors LLC, Rock Springs Capital Management LP, BlackRock Inc., and FMR LLC. This page lists 49 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.